Logo image of ASPI

ASP ISOTOPES INC (ASPI) Stock Fundamental Analysis

NASDAQ:ASPI - Nasdaq - US00218A1051 - Common Stock - Currency: USD

4.77  -0.13 (-2.65%)

After market: 4.76 -0.01 (-0.21%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ASPI. ASPI was compared to 85 industry peers in the Chemicals industry. While ASPI seems to be doing ok healthwise, there are quite some concerns on its profitability. ASPI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ASPI had negative earnings in the past year.
In the past year ASPI has reported a negative cash flow from operations.
ASPI Yearly Net Income VS EBIT VS OCF VS FCFASPI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -5M -10M -15M

1.2 Ratios

ASPI has a worse Return On Assets (-35.77%) than 91.57% of its industry peers.
ASPI's Return On Equity of -77.77% is on the low side compared to the rest of the industry. ASPI is outperformed by 89.16% of its industry peers.
Industry RankSector Rank
ROA -35.77%
ROE -77.77%
ROIC N/A
ROA(3y)-45.1%
ROA(5y)N/A
ROE(3y)-64.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ASPI Yearly ROA, ROE, ROICASPI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 -20 -40 -60 -80

1.3 Margins

ASPI's Gross Margin of 33.48% is fine compared to the rest of the industry. ASPI outperforms 65.06% of its industry peers.
ASPI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ASPI Yearly Profit, Operating, Gross MarginsASPI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 -1K -2K -3K

5

2. Health

2.1 Basic Checks

ASPI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ASPI has been increased compared to 1 year ago.
The debt/assets ratio for ASPI is higher compared to a year ago.
ASPI Yearly Shares OutstandingASPI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M 40M
ASPI Yearly Total Debt VS Total AssetsASPI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

ASPI has an Altman-Z score of 3.68. This indicates that ASPI is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.68, ASPI belongs to the top of the industry, outperforming 81.93% of the companies in the same industry.
ASPI has a Debt/Equity ratio of 0.87. This is a neutral value indicating ASPI is somewhat dependend on debt financing.
ASPI has a worse Debt to Equity ratio (0.87) than 63.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF N/A
Altman-Z 3.68
ROIC/WACCN/A
WACC9.05%
ASPI Yearly LT Debt VS Equity VS FCFASPI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 7.55 indicates that ASPI has no problem at all paying its short term obligations.
ASPI's Current ratio of 7.55 is amongst the best of the industry. ASPI outperforms 98.80% of its industry peers.
A Quick Ratio of 7.54 indicates that ASPI has no problem at all paying its short term obligations.
ASPI has a Quick ratio of 7.54. This is amongst the best in the industry. ASPI outperforms 98.80% of its industry peers.
Industry RankSector Rank
Current Ratio 7.55
Quick Ratio 7.54
ASPI Yearly Current Assets VS Current LiabilitesASPI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M 8M 10M

1

3. Growth

3.1 Past

ASPI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -32.74%.
EPS 1Y (TTM)-32.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.59%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, ASPI will show a very strong growth in Earnings Per Share. The EPS will grow by 27.07% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-18.75%
EPS Next 2Y29.9%
EPS Next 3Y28.56%
EPS Next 5Y27.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ASPI Yearly Revenue VS EstimatesASPI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
ASPI Yearly EPS VS EstimatesASPI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ASPI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ASPI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ASPI Price Earnings VS Forward Price EarningsASPI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ASPI Per share dataASPI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6

4.3 Compensation for Growth

ASPI's earnings are expected to grow with 28.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.9%
EPS Next 3Y28.56%

0

5. Dividend

5.1 Amount

No dividends for ASPI!.
Industry RankSector Rank
Dividend Yield N/A

ASP ISOTOPES INC

NASDAQ:ASPI (2/21/2025, 8:01:58 PM)

After market: 4.76 -0.01 (-0.21%)

4.77

-0.13 (-2.65%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-19 2024-11-19/amc
Earnings (Next)N/A N/A
Inst Owners44.73%
Inst Owner Change45.82%
Ins Owners18.58%
Ins Owner Change13.4%
Market Cap340.53M
Analysts82.5
Price Target6.63 (38.99%)
Short Float %31.41%
Short Ratio6.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)44.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-128%
EPS NY rev (3m)-128%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-48.1%
Revenue NY rev (3m)-48.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 100.65
P/FCF N/A
P/OCF N/A
P/B 8.8
P/tB 9.66
EV/EBITDA N/A
EPS(TTM)-0.61
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS0.05
BVpS0.54
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.77%
ROE -77.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.48%
FCFM N/A
ROA(3y)-45.1%
ROA(5y)N/A
ROE(3y)-64.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2050.22%
Cap/Sales 280.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.55
Quick Ratio 7.54
Altman-Z 3.68
F-Score5
WACC9.05%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.59%
EPS Next Y-18.75%
EPS Next 2Y29.9%
EPS Next 3Y28.56%
EPS Next 5Y27.07%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-68.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-4.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.09%
OCF growth 3YN/A
OCF growth 5YN/A